Date published: 2025-12-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

DMBT1 Inhibitors

DMBT1 Inhibitors includes a variety of specific compounds known to influence pathways and processes that regulate the expression and activity of DMBT1. Immunosuppressants like Cyclosporine A and glucocorticoids such as Dexamethasone and Prednisolone can alter immune response pathways, potentially leading to the downregulation of DMBT1. Proteasome inhibitors like Bortezomib, and HDAC inhibitors such as Trichostatin A, can affect gene expression and cellular signaling, potentially impacting DMBT1. Inhibitors of key signaling molecules, including LY294002 (PI3K inhibitor), JAK Inhibitor I, SP600125 (JNK inhibitor), and Wortmannin, are capable of modulating pathways that might influence DMBT1 expression or activity. Additionally, compounds like Sulforaphane and Curcumin, known for their diverse effects on cellular pathways, may also serve as indirect inhibitors of DMBT1 under specific conditions.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cyclosporin A

59865-13-3sc-3503
sc-3503-CW
sc-3503A
sc-3503B
sc-3503C
sc-3503D
100 mg
100 mg
500 mg
10 g
25 g
100 g
$62.00
$90.00
$299.00
$475.00
$1015.00
$2099.00
69
(5)

An immunosuppressant that can alter immune response pathways, potentially leading to the downregulation of DMBT1.

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$76.00
$82.00
$367.00
36
(1)

A synthetic glucocorticoid that can suppress inflammatory responses and might inhibit DMBT1 in immune-related pathways.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

An mTOR inhibitor, Rapamycin can affect cellular growth and immune response pathways, potentially leading to the inhibition of DMBT1.

Prednisolone

50-24-8sc-205815
sc-205815A
1 g
5 g
$82.00
$248.00
2
(1)

A glucocorticoid that can suppress the immune system and inflammatory responses, potentially reducing DMBT1 expression.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

A proteasome inhibitor used in cancer therapy, Bortezomib can affect various signaling pathways, potentially including those regulating DMBT1.

D,L-Sulforaphane

4478-93-7sc-207495A
sc-207495B
sc-207495C
sc-207495
sc-207495E
sc-207495D
5 mg
10 mg
25 mg
1 g
10 g
250 mg
$150.00
$286.00
$479.00
$1299.00
$8299.00
$915.00
22
(1)

While known for its activation properties in some contexts, Sulforaphane can also modulate various cellular pathways and might have an inhibitory effect on DMBT1 under certain conditions.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

A histone deacetylase (HDAC) inhibitor that changes chromatin structure and gene expression, potentially affecting DMBT1 expression.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A PI3K inhibitor that can affect AKT signaling, potentially leading to the reduced expression or activity of DMBT1.

JAK Inhibitor I

457081-03-7sc-204021
sc-204021A
500 µg
1 mg
$153.00
$332.00
59
(1)

A specific inhibitor of Janus kinases, which are part of the JAK-STAT signaling pathway, potentially reducing DMBT1 expression.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

An inhibitor of JNK, part of the MAPK pathway. By inhibiting JNK, it could reduce stress-induced activation of DMBT1.